Milestone Scientific (MLSS) Cash & Current Investments (2010 - 2026)

Milestone Scientific has reported Cash & Current Investments for 17 years, with the latest figure at $1.6 million in Q1 2026.

• Quarterly Cash & Current Investments fell 48.28% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (down 48.28% YoY) and the FY2025 annual result came in at $2.5 million, down 44.69% from the prior year.
• Cash & Current Investments declined to $1.6 million in Q1 2026 per MLSS's latest filing, from $2.5 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $14.5 million in Q1 2022 and troughed at $1.6 million in Q1 2026.
• A 5-year average of $5.7 million and a median of $4.6 million in 2024 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2023 and 2024: Cash & Current Investments sank 76.28% in 2023, then soared 45.81% in 2024.
• Over 5 years, Cash & Current Investments stood at $8.7 million in 2022, then slumped by 49.77% to $4.4 million in 2023, then grew by 4.12% to $4.6 million in 2024, then plunged by 44.69% to $2.5 million in 2025, then tumbled by 34.55% to $1.6 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $1.6 million, $2.5 million, and $2.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.